• Thu, May 5, 2022

Ed Arce Maintained (AUPH) at Strong Buy with Decreased Target to $30 on, May 5th, 2022

Ed Arce of HC Wainwright & Co., Maintained "Aurinia Pharmaceuticals Inc." (AUPH) at Strong Buy with Decreased Target from $33 to $30 on, May 5th, 2022.

Ed has made no other calls on AUPH in the last 4 months.



There are 2 other peers that have a rating on AUPH. Out of the 2 peers that are also analyzing AUPH, 0 agree with Ed's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Ed


  • Douglas Miehm of "RBC Capital" Maintained at Buy with Decreased Target to $22 on, Thursday, April 28th, 2022
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $22 on, Tuesday, March 8th, 2022